Biotech Consultant Hit With Insider Trading Charges
Boston federal prosecutors have accused an Oregon biotechnology consultant of insider trading through the use of confidential information he learned ahead of a planned 2017 acquisition of Dimension Therapeutics by another biotech...To view the full article, register now.
Already a subscriber? Click here to view full article